Multiple organ dysfunction syndrome (MODS) is where two or more independent organs fail to function properly. It is a serious condition that can lead to death without emergency care. MODS can affect ...

When a person develops multiple myeloma, a cancer of the plasma cells, the cancer produces large amounts of abnormal antibodies called monoclonal proteins, or M proteins. Some call this an M spike.

At Fred Hutch Cancer Center, our team of experts cares for people with multiple myeloma every day. Here, you will receive comprehensive multiple myeloma treatment from providers who are dedicated to ...

Multiple myeloma is a cancer of the blood that affects plasma cells, and its progression is determined using the Durie-Salmon Staging System or the Revised International Staging System (RISS). The ...

Multiple myeloma causes lytic or osteolytic lesions, which are areas of damage caused by cancerous plasma cells blocking natural bone growth. These lesions appear as small holes on X-rays. They often ...

The idea that multiple sclerosis is a disseminated plaque-like sclerosis was established approximately 150 years ago; indeed, the demonstration of dissemination — in space (disease-related changes in ...

Refractory multiple myeloma means that your blood cancer isn’t responding to treatment. Your doctor may also refer to this as “progressive disease.” Hearing that your treatment isn’t slowing the ...

Multiple myeloma is a cancer of your bone marrow. Specifically, it affects your plasma cells, which are white blood cells that make antibodies to fight germs and prevent infection and disease. When ...

Jan. 14, 2025 A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings ...

Multiple sclerosis, or MS, is a disease of the central nervous system that causes symptoms throughout the body. The progressive condition causes scar tissue, called lesions, along the nerve fibers in ...